Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simonetta Bandiera

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
JCI Insight|July 8, 2022
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivationEmilie Crouchet, Shen Li, Mozhdeh Sojoodi, et al.
Gastroenterology|March 6, 2019
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic ResponseNourdine Hamdane, Frank Jühling, Emilie Crouchet, et al.
Nature Biotechnology|March 24, 2015
Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibodyLaurent Mailly, Fei Xiao, Joachim Lupberger, et al.
Gastroenterology|April 13, 2019
Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease DevelopmentJoachim Lupberger, Tom Croonenborghs, Armando Andres Roca Suarez, et al.
Journal of Hepatology|October 29, 2022
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironmentNatascha Roehlen, Marion Muller, Zeina Nehme, et al.
Nature Communications|September 18, 2021
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discoveryEmilie Crouchet, Simonetta Bandiera, Naoto Fujiwara, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
JCI Insight|July 8, 2022
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivationEmilie Crouchet, Shen Li, Mozhdeh Sojoodi, et al.
Gastroenterology|March 6, 2019
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic ResponseNourdine Hamdane, Frank Jühling, Emilie Crouchet, et al.
Nature Biotechnology|March 24, 2015
Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibodyLaurent Mailly, Fei Xiao, Joachim Lupberger, et al.
Gastroenterology|April 13, 2019
Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease DevelopmentJoachim Lupberger, Tom Croonenborghs, Armando Andres Roca Suarez, et al.
Journal of Hepatology|October 29, 2022
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironmentNatascha Roehlen, Marion Muller, Zeina Nehme, et al.
Nature Communications|September 18, 2021
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discoveryEmilie Crouchet, Simonetta Bandiera, Naoto Fujiwara, et al.
Pageof 2